ORGANOGENESIS HOLDINGS INC. Capital Expenditures Incurred but Not yet Paid
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Capital Expenditures Incurred but Not yet Paid of $172.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2025-05-08
- ORGANOGENESIS HOLDINGS INC. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $172.00K, a 78.12% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. capital expenditures incurred but not yet paid for the quarter ending 2024-06-30 was -$77.00K.
- ORGANOGENESIS HOLDINGS INC. capital expenditures incurred but not yet paid for the quarter ending 2024-03-31 was $786.00K, a 60.42% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. capital expenditures incurred but not yet paid for the quarter ending 2023-12-31 was -$3.31M.
- ORGANOGENESIS HOLDINGS INC. capital expenditures incurred but not yet paid for fiscal 2023 was $841.00K, a 56.38% decline from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. capital expenditures incurred but not yet paid for fiscal 2022 was $1.93M, a 48.59% decline from fiscal 2021.
- ORGANOGENESIS HOLDINGS INC. capital expenditures incurred but not yet paid for fiscal 2021 was $3.75M, a 56.84% increase from fiscal 2020.
- ORGANOGENESIS HOLDINGS INC. capital expenditures incurred but not yet paid for fiscal 2020 was $2.39M, a 40.43% decline from fiscal 2019.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2025-03-31 | $172.00K 10-Q · filed 2025-05-08 | |||
| 2024-06-30 | -$77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $709.00K 10-Q · filed 2024-08-08 | -$2.60M derived: sum of 3 quarters · filed 2025-05-08 | -$332.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-03-31 | $786.00K 10-Q · filed 2025-05-08 | -$2.52M derived: sum of 2 quarters · filed 2025-05-08 | -$255.00K derived: sum of 3 quarters · filed 2025-05-08 | -$359.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$1.04M derived: sum of 2 quarters · filed 2024-02-29 | -$1.15M derived: sum of 3 quarters · filed 2024-08-08 | $841.00K 10-K · filed 2024-02-29 |
| 2023-09-30 | $2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.16M derived: sum of 2 quarters · filed 2024-08-08 | $4.15M 10-Q · filed 2023-11-09 | $527.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-06-30 | -$104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.88M 10-Q · filed 2024-08-08 | -$1.74M derived: sum of 3 quarters · filed 2024-08-08 | -$2.74M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.99M 10-Q · filed 2024-05-09 | -$1.63M derived: sum of 2 quarters · filed 2024-05-09 | -$2.63M derived: sum of 3 quarters · filed 2024-05-09 | $2.04M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$4.62M derived: sum of 2 quarters · filed 2024-02-29 | $59.00K derived: sum of 3 quarters · filed 2024-02-29 | $1.93M 10-K · filed 2024-02-29 |
| 2022-09-30 | -$999.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.68M derived: sum of 2 quarters · filed 2023-11-09 | $5.55M 10-Q · filed 2023-11-09 | $7.77M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $4.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $6.55M 10-Q · filed 2023-08-09 | $8.77M derived: sum of 3 quarters · filed 2024-02-29 | $5.95M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $1.87M 10-Q · filed 2023-05-10 | $4.10M derived: sum of 2 quarters · filed 2024-02-29 | $1.27M derived: sum of 3 quarters · filed 2024-02-29 | $5.31M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$599.00K derived: sum of 2 quarters · filed 2024-02-29 | $3.44M derived: sum of 3 quarters · filed 2024-02-29 | $3.75M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$2.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.22M derived: sum of 2 quarters · filed 2022-11-09 | $1.52M 10-Q · filed 2022-11-09 | $1.29M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $4.35M 10-Q · filed 2022-08-09 | $4.11M derived: sum of 3 quarters · filed 2023-03-01 | $2.05M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $306.00K 10-Q · filed 2022-05-10 | $69.00K derived: sum of 2 quarters · filed 2023-03-01 | -$2.00M derived: sum of 3 quarters · filed 2023-03-01 | -$245.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$2.30M derived: sum of 2 quarters · filed 2023-03-01 | -$551.00K derived: sum of 3 quarters · filed 2023-03-01 | $2.39M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$314.00K derived: sum of 2 quarters · filed 2021-11-09 | $2.63M 10-Q · filed 2021-11-09 | $2.94M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $4.69M 10-Q · filed 2021-08-09 | $5.01M derived: sum of 3 quarters · filed 2022-03-01 | $7.07M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $2.94M 10-Q · filed 2021-05-11 | $3.26M derived: sum of 2 quarters · filed 2022-03-01 | $5.32M derived: sum of 3 quarters · filed 2022-03-01 | $6.54M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.38M derived: sum of 2 quarters · filed 2022-03-01 | $3.60M derived: sum of 3 quarters · filed 2022-03-01 | $4.01M 10-K · filed 2022-03-01 |
| 2019-09-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $3.28M derived: sum of 2 quarters · filed 2020-11-09 | $3.70M 10-Q · filed 2020-11-09 | $3.83M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.64M 10-Q · filed 2020-08-10 | $1.77M derived: sum of 3 quarters · filed 2021-03-16 | |
| 2019-03-31 | $415.00K 10-Q · filed 2020-05-11 | $548.00K derived: sum of 2 quarters · filed 2021-03-16 | ||
| 2018-12-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $172.00K 10-K · filed 2021-03-16 | ||
| 2018-09-30 | $39.00K 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | $764.00K 10-K · filed 2020-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |